EurekAlert! -
24 Jul 2019 06:00
(Kessler Foundation) Impairments in new learning and memory negatively affect the everyday lives of many individuals with multiple sclerosis, Few individuals receive treatment for these impairments because of the Lack of Class I evidence for targeted cognitive rehabilitation interventions. To address the need for evidence, the Kessler team will conduct a double-blinded, placebo-controlled, randomized controlled trial of 120 participants with multiple sclerosis and deficits in learning and memory...
Share this Article